Critical Therapeutics Report issue

For profit Phase 2 Phase 4
Founded: Lexington MA United States (2000)
Status: Acquired by Cornerstone Therapeutics (2008) → now Chiesi (2014)

Organization Overview

First Clinical Trial
2004
NCT00098358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Critical Therapeutics/Clinquest Inc

Active Ingredients

Drugs in Phase 4 Trials (1)

zileuton (zyflo) (4 trials)

Drugs in Phase 2 Trials (1)

pyruvic acid, ethyl ester (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Asthma (Phase 4)

Coronary Disease (Phase 2)

Heart Valve Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 2